Key statistics
As of last trade Liquidia Corp (LT4:FRA) traded at 25.74, -34.47% below its 52-week high of 39.28, set on Feb 04, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 25.74 |
|---|---|
| High | 25.74 |
| Low | 25.74 |
| Bid | 25.88 |
| Offer | 26.38 |
| Previous close | 25.82 |
| Average volume | 448.00 |
|---|---|
| Shares outstanding | 87.00m |
| Free float | 75.17m |
| P/E (TTM) | -- |
| Market cap | 2.70bn USD |
| EPS (TTM) | -1.43 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 07:09 GMT.
More ▼
Announcements
- Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026
- Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress
- Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
- Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference
- Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences
- Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update
- Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025
- Liquidia Corporation to Host R&D Day in New York City on October 28, 2025
- Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting
- Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium
More ▼
